"Rīgas Austrumu klīniskā universitātes slimnīca" SIA

The Rīgas Austrumu klīniskā universitātes slimnīca cardiology department focuses on advancing care for cardiovascular disease and related conditions.

• Evaluating novel therapies to reduce major cardiac events
• Assessing combination treatments for heart failure outcomes
• Investigating lipid‑lowering agents for severe hypertriglyceridemia

These studies aim to improve survival and quality of life for patients with heart disease, hypertension, and associated metabolic risks.

Research at the site also targets nutritional and metabolic diseases, especially type 2 diabetes and related lipid disorders.

• Testing innovative drugs to lower fasting triglyceride levels
• Studying glucose‑lowering agents combined with blood‑pressure control
• Exploring strategies to reduce overall metabolic risk in diabetic patients

These trials seek to provide new therapeutic options that address both blood sugar and lipid abnormalities, helping to prevent cardiovascular complications.